000 01470 a2200409 4500
005 20250511220817.0
264 0 _c19910715
008 199107s 0 0 eng d
022 _a1053-8550
024 7 _a10.1097/00002371-199104000-00008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBernstein, Z P
245 0 0 _aInterleukin-2 lymphokine-activated killer cell therapy of non-Hodgkin's lymphoma and Hodgkin's disease.
_h[electronic resource]
260 _bJournal of immunotherapy : official journal of the Society for Biological Therapy
_cApr 1991
300 _a141-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHodgkin Disease
_xtherapy
650 0 4 _aHumans
650 0 4 _aImmunotherapy, Adoptive
_xadverse effects
650 0 4 _aInterleukin-2
_xadministration & dosage
650 0 4 _aKiller Cells, Lymphokine-Activated
650 0 4 _aLymphoma, Non-Hodgkin
_xtherapy
700 1 _aVaickus, L
700 1 _aFriedman, N
700 1 _aGoldrosen, M H
700 1 _aWatanabe, H
700 1 _aRahman, R
700 1 _aArbuck, S G
700 1 _aSweeney, J
700 1 _aVesper, D
700 1 _aHenderson, E D
773 0 _tJournal of immunotherapy : official journal of the Society for Biological Therapy
_gvol. 10
_gno. 2
_gp. 141-6
856 4 0 _uhttps://doi.org/10.1097/00002371-199104000-00008
_zAvailable from publisher's website
999 _c2049775
_d2049775